bpc-157 human clinical trial 2023 2024 2025 and the gut–brain axis: emerging links between cytoprotection and neuroregeneration The “Wolverine” Drug – Ortho
Description
doi: 10.1359/JBMR.0301263
The biological role and timing of the CSD pathway is still unknown
While clinical trials conducted in Croatia in the early 2000s determined BPC 157 to be safe and effective in humans for the treatment of inflammatory bowel disease, there appears to be a lack of trials conducted in the U.S
What if BPC-157 doesn't help my GLP-1 side effects
Gee, MD, FACOG
